Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|March 12, 2024
Sub-MIC levels of bedaquiline and clofazimine can select Mycobacterium tuberculosis mutants with increased MICCristina Villellas, Frederik Stevenaert, Bart Remmerie, et al.Schizophrenia Research|July 13, 2004
Pharmacokinetics and tolerability of long-acting risperidone in schizophreniaMariëlle Eerdekens, Ilse Van Hove, Bart Remmerie, et al.Clinical Pharmacology in Drug Development|July 2, 2016
Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or AripiprazoleBart Remmerie, Marc De Meulder, Jay Ariyawansa, et al.Clinical Pharmacology in Drug Development|July 2, 2016
Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or AripiprazoleBart Remmerie, Marc De Meulder, Sveta Weiner, et al.Clinical Therapeutics|May 3, 2007
Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerabilityAn Thyssen, Bart Remmerie, Peter D'Hoore, et al.Schizophrenia Research|May 29, 2018
Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studyRama Melkote, Arun Singh, An Vermeulen, et al.European Journal of Clinical Pharmacology|February 3, 2018
Determination of plasma concentration reference ranges for oral aripiprazole, olanzapine, and quetiapineJulia Korell, Bruce Green, Allan Rae, et al.The AAPS Journal|March 16, 2019
A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds-Application to Simulated Risperidone Data in Schizophrenic PatientsCarlos Pérez-Ruixo, Bart Remmerie, Juan José Peréz-Ruixo, et al.Journal of Clinical Pharmacology|September 29, 2015
Drug-Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended-Release Tablets in Healthy Participants and Patients with Psychiatric DisordersBart Remmerie, Jay Ariyawansa, Marc De Meulder, et al.Clinical Pharmacology in Drug Development|April 30, 2016
Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-stateVirginie Kerbusch-Herben, Adriaan Cleton, Joris Berwaerts, et al.Pageof 4